drugs

Health care is a component of modern prosperity, which must be continually created.

There is no question that a means testing regime ought to be in place, but by what standards and who makes that determination is what must be reexamined and changed.

Nearly six million Americans of all ages are living with Alzheimer’s disease, and more than 16 million Americans care for people living with Alzheimer’s and other dementias.

The FDA has unlimited power and control when it comes to the treatments and therapies terminally ill patients can access.

According to a new analysis released last month, Americans spent $3.65 trillion dollars on health care in 2018 – more than the entire gross domestic product of Canada.

If the government is the ultimate authority on your “health care,” remember that its tools for checking whether a child has a life-threatening disease such as meningitis include battering rams and assault rifles.

At last, regulatory flexibility for the seriously ill from the FDA.

Right to try establishes that Americans and not bureaucrats decide about trying a potentially life-saving drug.

The other day a reporter asked me to explain why the government cannot negotiate the price of Medicare drugs lower than private drug plans run by pharmacy benefit managers (PBMs).

Over the past five years, health care access has deteriorated in Idaho.

Before 1990, American physicians who had completed 3 years or more of rigorous training in a specialty and passed an examination were awarded lifetime “board certification.”

In November, Maine residents will be confronted with a ballot question asking them to expand MaineCare.

Almost everyone involved in health care will tell you that the greatest problem in our system is that we pay on a fee-for-service basis. Almost everyone is wrong.